Novel Immunotherapy Combinations-Reference-Cited by-同舟云学术

Novel Immunotherapy Combinations

Published:2019-11 Issue:11 Volume:21 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Bashir Babar,Wilson Melissa A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-019-0851-x.pdf

Reference99 articles.

1. The Nobel Prize in Physiology or Medicine 2018. NobelPrize.org . Nobel Media AB 2019. Thu. 18 Apr 2019. https://www.nobelprize.org/prizes/medicine/2018/summary/ . Accessed 26 April 2019

2. Serrone L, et al. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. (0392–9078 (Print)).

3. Middleton MR, et al. Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma. J Clin Oncol. 2000;18(1):158.

4. Flaherty KT, et al. Final results of E2603: A double-blind, randomized phase III trial comparing carboplatin (C)/paclitaxel (P) with or without sorafenib (S) in metastatic melanoma. J Clin Oncol. 2010;28(15_suppl):8511.

5. Hersh EM, et al. A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma. Ann Oncol. 2015;26(11):2267–74.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial;Cancer;2024-04-02

2. Immune Checkpoint Inhibitors: Recent Clinical Advances and Future Prospects;Current Medicinal Chemistry;2023-08

3. Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management;Expert Review of Clinical Pharmacology;2023-05-04

4. An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma;Frontiers in Oncology;2022-03-15

5. Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data;Frontiers in Oncology;2022-03-15